Aragen secures $100 million funding from Quadria Capital
HYDERABAD: Contract analysis, improvement and manufacturing organisation (CRDMO) Aragen Life Science, previously often known as GVK Biosciences, has secured a $100 million (approx. Rs 865 crore) funding from healthcare targeted personal fairness fund Quadria Capital.The deal will see Quadria, which is targeted on the Asian healthcare sector, purchase a minority stake in Aragen at an…